Further comparative analysis of the expression of PDGFD and PDGFRB with clinical characteristics indicated no significant correlation between either of them and gender, age, tumor site, pathological staging, neoadjuvant chemotherapy, maximum tumor diameter, necrosis rate, local recurrence, or distant metastasis. The gene discussed is PDGFRB; the disease is neoplasm.